<DOC>
	<DOCNO>NCT00497159</DOCNO>
	<brief_summary>This study evaluate safety 3 month Dimebon dose efficacy Dimebon improve cognitive , motor , overall function subject Huntington 's Disease .</brief_summary>
	<brief_title>A Study Novel Drug Dimebon Patients With Huntington 's Disease</brief_title>
	<detailed_description />
	<mesh_term>Huntington Disease</mesh_term>
	<criteria>Clinical feature HD confirmatory family history HD , and/or genetically confirm HD ; Able take medication ( capsule ) mouth . Clinical evidence unstable medical illness ; Females pregnant lactate intend become pregnant study period .</criteria>
	<gender>All</gender>
	<minimum_age>29 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2015</verification_date>
	<keyword>Trial Dimebon treat patient mild-to-moderate Huntington 's disease .</keyword>
</DOC>